'I was happy losing a pound a week' — why this Zepbound patient refused a higher dose
A Zepbound patient chose not to increase their medication dosage while losing weight steadily. A physician advises against rushing dose escalation and cautions against unnecessary Shingrix boosters.
A physician advises that GLP-1 patients need not rush dose escalation, and cautions against a third Shingrix booster until more long-term data becomes available.
READ NEXT
More on the wire
AI TLDR
Two giant pandas, Ping Ping and Fu Shuang, have arrived at Zoo Atlanta. The pair will reside at the zoo on a 10-year loan from China.
FROM THE PUBLISHER
Letters to the Editor can be submitted to letters@oregonian.com with full name and place of residence.
AI TLDR
The Oregon Attorney General has issued subpoenas for records related to 'Made in Old Town,' a sneaker manufacturing project in Portland that failed after receiving public funding.